Senti Biosciences (SNTI) Non-Current Assets (2021 - 2025)

Senti Biosciences has reported Non-Current Assets for 5 years, with the latest figure at $27.9 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets fell 28.11% year-over-year to $27.9 million; the trailing twelve-month figure through Dec 2025 stood at $136.1 million (down 19.16% YoY), and the FY2025 full-year result was $27.9 million, down 28.11% from the prior year.
• Non-Current Assets for Q4 2025 stood at $27.9 million, down from $34.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $230.1 million in Q1 2022, with the low at $27.9 million in Q4 2025.
• Average Non-Current Assets over 5 years is $78.9 million, with a median of $48.3 million recorded in 2023.
• Peak annual rise in Non-Current Assets reached 114.23% in 2022, while the deepest fall reached 74.59% in 2022.
• Tracing SNTI's Non-Current Assets over 5 years: stood at $36.5 million in 2021, then surged by 114.23% to $78.2 million in 2022, then slumped by 38.27% to $48.3 million in 2023, then declined by 19.48% to $38.9 million in 2024, then fell by 28.11% to $27.9 million in 2025.
• The last three Non-Current Assets figures came in at $27.9 million (Q4 2025), $34.5 million (Q3 2025), and $36.0 million (Q2 2025), per Business Quant data.

Peer Comparison